tiprankstipranks
Shanghai Pharmaceuticals Holding Co Ltd Class H (SHPMF)
OTHER OTC:SHPMF

Shanghai Pharmaceuticals Holding Co (SHPMF) Stock Forecast & Price Target

9 Followers
See the Price Targets and Ratings of:

SHPMF Analyst Ratings

Moderate Buy
1Ratings
1 Buy
0 Hold
0 Sell
Based on 1 analysts giving stock ratings to
Shanghai
Pharmaceuticals Holding Co
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

SHPMF Stock 12 Months Forecast

Average Price Target

$2.30
▲(54.88% Upside)
Based on 1 Wall Street analysts offering 12 month price targets for Shanghai Pharmaceuticals Holding Co in the last 3 months. The average price target is $2.30 with a high forecast of $2.30 and a low forecast of $2.30. The average price target represents a 54.88% change from the last price of $1.48.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"plus_tr_sans","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"$0","3":"$3","0.75":"$0.75","1.5":"$1.5","2.25":"$2.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":2.30127534,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n  <span style=\"color:#199ca5\">$2.30</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2.3,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n  <span style=\"color:#828080\">$2.30</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2.30127534,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n  <span style=\"color:#912767\">$2.30</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,0.75,1.5,2.25,3],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2023","6":"Oct<br/>2023","9":"Dec<br/>2023","12":"Mar<br/>2024","25":"Mar<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.56,1.61702118,1.67404236,1.73106354,1.78808472,1.8451059,1.90212708,1.95914826,2.01616944,2.07319062,2.1302118,2.18723298,2.24425416,{"y":2.30127534,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.56,1.616923076923077,1.6738461538461538,1.7307692307692308,1.7876923076923077,1.8446153846153845,1.9015384615384614,1.9584615384615383,2.0153846153846153,2.0723076923076924,2.129230769230769,2.186153846153846,2.2430769230769227,{"y":2.3,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.56,1.61702118,1.67404236,1.73106354,1.78808472,1.8451059,1.90212708,1.95914826,2.01616944,2.07319062,2.1302118,2.18723298,2.24425416,{"y":2.30127534,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1.86,"date":1680307200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":2.03,"date":1682899200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1.96,"date":1685577600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1.98,"date":1688169600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1.8,"date":1690848000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1.65,"date":1693526400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1.47,"date":1696118400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1.46,"date":1698796800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1.48,"date":1698969600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.38,"date":1701388800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.5,"date":1704412800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":1.47,"date":1706832000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.56,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$2.30Average Price Target$2.30Lowest Price Target$2.30
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Goldman Sachs
$1.79
Sell
20.36%
Upside
Reiterated
10/30/23
Shanghai Pharmaceuticals Holdings (2607:HK) (FJLLF) PT Lowered to HK$13.98 at Goldman SachsGoldman Sachs analyst Ziyi Chen lowered the price target on Shanghai Pharmaceuticals Holdings (2607:HK) (OTC: FJLLF) to HK$13.98 (from HK$14.40) while maintaining a Sell rating.
Citi Analyst forecast on SHPMF
Unknown Analyst
Not Ranked
Citi
$2.24
Buy
50.66%
Upside
Reiterated
11/07/23
Shanghai Pharmaceuticals Holdings (2607:HK) (FJLLF) PT Lowered to HK$17.50 at CitiCiti analyst David Shang lowered the price target on Shanghai Pharmaceuticals Holdings (2607:HK) (OTC: FJLLF) to HK$17.50 (from HK$19.00) while maintaining a Buy rating.

Best Analysts Covering Shanghai Pharmaceuticals Holding Co

Which Analyst Should I Follow If I Want to Buy SHPMF and Sell After:
1 Month
Ziyi ChenGoldman Sachs
Success Rate
1/1 ratings generated profit
100%
Average Return
+7.30%
reiterated a sell rating 5 months ago
Copying Ziyi Chen's trades and holding each position for 1 Month would result in 100.00% of your transactions generating a profit, with an average return of +7.30% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
3 Months
Laurence TamMorgan Stanley
Success Rate
1/1 ratings generated profit
100%
Average Return
+10.00%
reiterated a buy rating 3 months ago
Copying Laurence Tam's trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +10.00% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
1 Year
Laurence TamMorgan Stanley
Success Rate
1/1 ratings generated profit
100%
Average Return
+10.00%
reiterated a buy rating 3 months ago
Copying Laurence Tam's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +10.00% per trade.
2 Years
Laurence TamMorgan Stanley
Success Rate
1/1 ratings generated profit
100%
Average Return
+10.00%
reiterated a buy rating 3 months ago
Copying Laurence Tam's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +10.00% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SHPMF Analyst Recommendation Trends

Rating
Apr 21
Oct 23
Nov 23
Dec 23
Strong Buy
0
0
1
2
Buy
0
0
0
0
Hold
1
1
1
0
Sell
0
1
1
1
Strong Sell
0
0
0
0
total
1
2
3
3
In the current month, SHPMF has received 2 Buy Ratings, 0 Hold Ratings, and 1 Sell Ratings. SHPMF average Analyst price target in the past 3 months is $2.30.
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

SHPMF Financial Forecast

SHPMF Earnings Forecast

Next quarter’s earnings estimate for SHPMF is $0.06 with a range of $0.05 to $0.07. The previous quarter’s EPS was $0.04. SHPMF beat its EPS estimate 33.33% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.46% of the time in the same period. In the last calendar year SHPMF has Underperformed its overall industry.
Next quarter’s earnings estimate for SHPMF is $0.06 with a range of $0.05 to $0.07. The previous quarter’s EPS was $0.04. SHPMF beat its EPS estimate 33.33% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.46% of the time in the same period. In the last calendar year SHPMF has Underperformed its overall industry.

SHPMF Sales Forecast

Next quarter’s sales forecast for SHPMF is $8.74B with a range of $8.74B to $8.74B. The previous quarter’s sales results were $8.93B. SHPMF beat its sales estimates 33.33% of the time in past 12 months, while its overall industry beat sales estimates 47.32% of the time in the same period. In the last calendar year SHPMF has Underperformed its overall industry.
Next quarter’s sales forecast for SHPMF is $8.74B with a range of $8.74B to $8.74B. The previous quarter’s sales results were $8.93B. SHPMF beat its sales estimates 33.33% of the time in past 12 months, while its overall industry beat sales estimates 47.32% of the time in the same period. In the last calendar year SHPMF has Underperformed its overall industry.

SHPMF Stock Forecast FAQ

What is SHPMF’s average 12-month price target, according to analysts?
Based on analyst ratings, Shanghai Pharmaceuticals Holding Co Ltd Class H’s 12-month average price target is $2.30.
    What is SHPMF’s upside potential, based on the analysts’ average price target?
    Shanghai Pharmaceuticals Holding Co Ltd Class H has 54.88% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is SHPMF a Buy, Sell or Hold?
          Shanghai Pharmaceuticals Holding Co Ltd Class H has a conensus rating of Moderate Buy which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Shanghai Pharmaceuticals Holding Co Ltd Class H’s price target?
            The average price target for Shanghai Pharmaceuticals Holding Co Ltd Class H is $2.30. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $2.30 ,the lowest forecast is $2.30. The average price target represents 54.88% Increase from the current price of $1.485.
              What do analysts say about Shanghai Pharmaceuticals Holding Co Ltd Class H?
              Shanghai Pharmaceuticals Holding Co Ltd Class H’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.
                How can I buy shares of SHPMF?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis